Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices (2008)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ab.2007.11.020
- Subjects: METALOPROTEINASES; LEUCEMIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Analytical Biochemistry
- ISSN: 0003-2697
- Volume/Número/Paginação/Ano: v. 374, n. 1, p. 56-63, 2008
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MANNELLO, Ferdinando et al. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, v. 374, n. 1, p. 56-63, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ab.2007.11.020. Acesso em: 18 jan. 2026. -
APA
Mannello, F., Tanus-Santos, J. E., Meschiari, C. A., & Tonti, G. A. (2008). Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, 374( 1), 56-63. doi:10.1016/j.ab.2007.11.020 -
NLM
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2026 jan. 18 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020 -
Vancouver
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2026 jan. 18 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020 - Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Simvastatin treatment increases nitrite levels in obese women: Modulation by T−786C polymorphism of eNOS
- Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia
- Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro
- Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
Informações sobre o DOI: 10.1016/j.ab.2007.11.020 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
